Page last updated: 2024-10-22

amitriptyline and Paraparesis

amitriptyline has been researched along with Paraparesis in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Paraparesis: Mild to moderate loss of bilateral lower extremity motor function, which may be a manifestation of SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; MUSCULAR DISEASES; INTRACRANIAL HYPERTENSION; parasagittal brain lesions; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anand, J1
Sivaraman Nair, KP1
Taly, AB1
Murali, T1

Other Studies

1 other study available for amitriptyline and Paraparesis

ArticleYear
Spontaneous expulsion of large vesicle calculi in a woman with paraparesis.
    Spinal cord, 1999, Volume: 37, Issue:10

    Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Female; Humans; India; Myelitis, Transverse;

1999